Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Germany: Ares invests in Linimed to support growth strategy in intensive community care and rehabilitation therapy services

Homecare Nick Herbert -
Linimed Gruppe, a leading provider of community‑based intensive care services in Germany, has secured capital from funds managed by Ares Management. “Partnering with Ares marks an important milestone in Linimed’s evolution and provides us with the capital to accelerate our strategic expansion plans, building on our successful ongoing partnership with...

Belgium: UCB expanding capabilities in next‑generation biologics with acquisition of Candid Therapeutics

M&A Nick Herbert -
Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, is to acquire Candid Therapeutics, a US-based privately held clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs) for a total transaction value of up to US$2.2bn - consisting of US$2bn in upfront payments plus up to US$200m in potential future milestone payments. The deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next‑generation biologics with potential for immune reset. Candid’s lead asset, cizutamig, a...